CHK1 IS A POTENTIAL THERAPEUTIC TARGET FOR BRAF INHIBITOR-RESISTANT MELANOMA
Cancer and Cell Biology
-
90915
Publications in other proceedings
-
XVI SO 2022
IMPACT OF BRAFV600 MUTATIONS IN THE CLINICAL AND HISTOPATHOLOGICAL CHARACTERISTICS OF ACRAL MELANOMA AND ITS DERIVED EXPERIMENTAL MODELS
-
XV SO 2021
IKAROS genes as potential regulators of CRLF2 expression in acute lymphoblastic leukaemias
-
XV SO 2021
PRELIMINARY CHARACTERIZATION OF SPONTANEOUS METASTASES IN A PATIENT-DERIVED XENOGRAFTS OF ACRAL MELANOMA
-
XIV SO 2020
ZNF429: A POTENTIAL NEW REGULATOR OF EXTRACELLULAR MATRIX REMODELING IN OVARIAN CANCER
